Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 17

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 17
---
. The Placement Agent Warrants will expire five years from the commencement of sales of the offering.
The Placement Agent Warrants will have substantially the same terms as the Warrants described above, except that the Placement Agent Warrants will have an exercise price of $2.0625 per share (representing 125% of the offering price of the
securities). See “Plan of Distribution” below.

S-13

DILUTION If you invest in our securities in this offering, your interest will be diluted to the extent of the difference between the public offering price per share of our Common Stock and the net tangible book value per share of our Common Stock upon consummation of this offering. Dilution results from the fact that the public offering price is substantially in excess of the book value per share attributable to the existing stockholders for the presently outstanding stock. The historical net tangible book value of our Common Stock, as of September 30, 2025, was approximately $(5.0) million, or approximately $(0.10) per share of Common Stock. Historical net tangible book value (deficit) per share is determined by dividing the number of outstanding shares of common stock into its total tangible assets (total assets less intangible assets) less total liabilities. Investors purchasing securities in this offering will incur immediate and substantial dilution. After giving effect to the sale of shares of our Common Stock and accompanying Warrants to purchase shares of Common Stock at the offering price of $1.65 per share, including sales of securities to K&V to occur on the second closing and third closing of this offering, and after deducting estimated offering costs payable by us, our as adjusted net tangible book value as of September 30, 2025 would have been approximately $9.4 million, or approximately $0.15 per share of Common Stock. This represents an immediate increase in net tangible book value of $0.25 per share to existing stockholders, and an immediate dilution in the as adjusted net tangible book value of $1.50 per share to investors purchasing shares of our Common Stock in this offering. The following table illustrates this per share dilution:

| Offering price                                                                              
 Historical net tangible book value per share as of September 30, 2025                       |     |   | (0.10 | ) |     |   | 1.65 |
|:--------------------------------------------------------------------------------------------|:----|:--|------:|:--|:----|:--|-----:|
| Increase in net tangible